| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.33e-13 | 37 | 40 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 8.97e-13 | 38 | 40 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.82e-06 | 430 | 40 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | N-acylphosphatidylethanolamine-specific phospholipase D activity | 1.17e-05 | 3 | 40 | 2 | GO:0070290 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.86e-05 | 654 | 40 | 8 | GO:0008233 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.28e-05 | 891 | 40 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.52e-05 | 37 | 40 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | phospholipase D activity | 1.09e-04 | 8 | 40 | 2 | GO:0004630 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.69e-04 | 262 | 40 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.13e-04 | 11 | 40 | 2 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.51e-04 | 14 | 40 | 2 | GO:0003964 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 4.66e-04 | 1189 | 40 | 9 | GO:0046914 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 8.02e-04 | 21 | 40 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.09e-03 | 127 | 40 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 2.23e-03 | 35 | 40 | 2 | GO:0051019 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 2.36e-03 | 36 | 40 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.49e-03 | 37 | 40 | 2 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.63e-03 | 38 | 40 | 2 | GO:0034061 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.76e-03 | 140 | 40 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.83e-03 | 46 | 40 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 4.00e-03 | 47 | 40 | 2 | GO:0004712 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 4.52e-03 | 167 | 40 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 7.97e-03 | 67 | 40 | 2 | GO:0031492 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.14e-03 | 891 | 40 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 8.95e-03 | 645 | 40 | 5 | GO:0140640 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.03e-02 | 938 | 40 | 6 | GO:0016772 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.08e-02 | 229 | 40 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.09e-02 | 79 | 40 | 2 | GO:0004521 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.20e-02 | 83 | 40 | 2 | GO:1990841 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 6.20e-07 | 85 | 40 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 6.20e-07 | 85 | 40 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 7.80e-07 | 89 | 40 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-8 ERVK-6 SMARCAD1 CHD4 INO80 HUWE1 PPP4R3C UBR5 TRRAP EP300 | 1.07e-05 | 959 | 40 | 10 | GO:0006974 |
| GeneOntologyBiologicalProcess | viral process | 2.73e-05 | 464 | 40 | 7 | GO:0016032 | |
| GeneOntologyBiologicalProcess | DNA repair | 2.87e-05 | 648 | 40 | 8 | GO:0006281 | |
| GeneOntologyBiologicalProcess | chromatin organization | 4.29e-05 | 896 | 40 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | DNA recombination | 7.12e-05 | 368 | 40 | 6 | GO:0006310 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 9.94e-05 | 999 | 40 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 1.48e-04 | 53 | 40 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TOGARAM1 INO80 HUWE1 PIP4K2C ARMH3 EP300 RPS6KA2 MAP3K1 HDAC2 TBC1D2 | 1.84e-04 | 1342 | 40 | 10 | GO:0033043 |
| GeneOntologyBiologicalProcess | DNA integration | 2.82e-04 | 13 | 40 | 2 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of sarcomere organization | 2.82e-04 | 13 | 40 | 2 | GO:0060297 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 4.33e-04 | 16 | 40 | 2 | GO:0061029 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 4.97e-04 | 741 | 40 | 7 | GO:0006338 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.36e-05 | 96 | 40 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 1.06e-04 | 129 | 40 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | NuRD complex | 4.77e-04 | 17 | 40 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 4.77e-04 | 17 | 40 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 5.75e-04 | 85 | 40 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.81e-04 | 596 | 40 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.31e-03 | 28 | 40 | 2 | GO:0097346 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.38e-03 | 254 | 40 | 4 | GO:0000228 | |
| GeneOntologyCellularComponent | chromatin | 1.61e-03 | 1480 | 40 | 9 | GO:0000785 | |
| HumanPheno | Abnormal toe morphology | SMG9 RPGRIP1 TOGARAM1 SMARCAD1 HUWE1 RHBDF2 PRDM5 TRRAP SLC35C1 EP300 | 3.35e-05 | 893 | 15 | 10 | HP:0001780 |
| Domain | PLipase_D1/D2 | 2.84e-06 | 2 | 32 | 2 | IPR016555 | |
| Domain | PLipase_D_fam | 2.84e-06 | 2 | 32 | 2 | IPR015679 | |
| Domain | PLDc_2 | 8.52e-06 | 3 | 32 | 2 | PF13091 | |
| Domain | PLD-like_dom | 8.52e-06 | 3 | 32 | 2 | IPR025202 | |
| Domain | PLDc | 1.70e-05 | 4 | 32 | 2 | PF00614 | |
| Domain | SNF2_N | 2.19e-05 | 32 | 32 | 3 | PF00176 | |
| Domain | SNF2_N | 2.19e-05 | 32 | 32 | 3 | IPR000330 | |
| Domain | PLDc | 4.25e-05 | 6 | 32 | 2 | SM00155 | |
| Domain | PLD | 5.94e-05 | 7 | 32 | 2 | PS50035 | |
| Domain | PLipase_D/transphosphatidylase | 5.94e-05 | 7 | 32 | 2 | IPR001736 | |
| Domain | ARM-type_fold | 2.57e-04 | 339 | 32 | 5 | IPR016024 | |
| Domain | zf-C2H2_jaz | 6.43e-04 | 22 | 32 | 2 | PF12171 | |
| Domain | Znf_C2H2_jaz | 6.43e-04 | 22 | 32 | 2 | IPR022755 | |
| Domain | Helicase_C | 8.03e-04 | 107 | 32 | 3 | PF00271 | |
| Domain | HELICc | 8.03e-04 | 107 | 32 | 3 | SM00490 | |
| Domain | Helicase_C | 8.25e-04 | 108 | 32 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 8.48e-04 | 109 | 32 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 8.48e-04 | 109 | 32 | 3 | PS51192 | |
| Domain | DEXDc | 8.48e-04 | 109 | 32 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 8.71e-04 | 110 | 32 | 3 | IPR014001 | |
| Domain | HECT | 9.72e-04 | 27 | 32 | 2 | PF00632 | |
| Domain | HECTc | 9.72e-04 | 27 | 32 | 2 | SM00119 | |
| Domain | HECT_dom | 9.72e-04 | 27 | 32 | 2 | IPR000569 | |
| Domain | HECT | 9.72e-04 | 27 | 32 | 2 | PS50237 | |
| Domain | PX | 2.57e-03 | 44 | 32 | 2 | SM00312 | |
| Domain | PX | 3.18e-03 | 49 | 32 | 2 | PF00787 | |
| Domain | SET_dom | 3.31e-03 | 50 | 32 | 2 | IPR001214 | |
| Domain | SET | 3.31e-03 | 50 | 32 | 2 | PS50280 | |
| Domain | PX | 3.31e-03 | 50 | 32 | 2 | PS50195 | |
| Domain | - | 3.44e-03 | 51 | 32 | 2 | 3.30.1520.10 | |
| Domain | Phox | 3.57e-03 | 52 | 32 | 2 | IPR001683 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.72e-07 | 30 | 24 | 4 | M27637 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.10e-05 | 26 | 24 | 3 | MM14793 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.54e-05 | 29 | 24 | 3 | MM15340 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 5.80e-05 | 7 | 24 | 2 | MM1569 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 5.80e-05 | 7 | 24 | 2 | M22054 | |
| Pathway | REACTOME_SYNTHESIS_OF_PG | 7.73e-05 | 8 | 24 | 2 | M26961 | |
| Pathway | REACTOME_PI5P_REGULATES_TP53_ACETYLATION | 9.93e-05 | 9 | 24 | 2 | M27655 | |
| Pathway | REACTOME_PI5P_REGULATES_TP53_ACETYLATION | 9.93e-05 | 9 | 24 | 2 | MM15357 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.42e-04 | 160 | 24 | 4 | M27498 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.46e-04 | 61 | 24 | 3 | M152 | |
| Pathway | WP_EGFEGFR_SIGNALING | 1.49e-04 | 162 | 24 | 4 | M39334 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 1.51e-04 | 11 | 24 | 2 | M42523 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.85e-04 | 66 | 24 | 3 | M101 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 2.64e-04 | 188 | 24 | 4 | MM15828 | |
| Pathway | PID_ARF6_DOWNSTREAM_PATHWAY | 2.88e-04 | 15 | 24 | 2 | M120 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 2.88e-04 | 15 | 24 | 2 | MM1439 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 3.15e-04 | 79 | 24 | 3 | M66 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 3.27e-04 | 80 | 24 | 3 | M223 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.29e-04 | 16 | 24 | 2 | MM1483 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M8516 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.18e-04 | 18 | 24 | 2 | M5290 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.77e-04 | 91 | 24 | 3 | M27101 | |
| Pathway | WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS | 5.18e-04 | 20 | 24 | 2 | M48330 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 5.72e-04 | 21 | 24 | 2 | MM1463 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 5.72e-04 | 21 | 24 | 2 | M8601 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 6.48e-04 | 101 | 24 | 3 | M1979 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 7.25e-04 | 105 | 24 | 3 | M27425 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 7.25e-04 | 105 | 24 | 3 | M164 | |
| Pathway | REACTOME_ADIPOGENESIS | 8.30e-04 | 110 | 24 | 3 | M48259 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M2499 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 9.50e-04 | 27 | 24 | 2 | MM14779 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.06e-03 | 272 | 24 | 4 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 1.17e-03 | 30 | 24 | 2 | M42517 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 1.25e-03 | 31 | 24 | 2 | M48258 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.34e-03 | 32 | 24 | 2 | M39521 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 1.34e-03 | 32 | 24 | 2 | M275 | |
| Pathway | KEGG_ETHER_LIPID_METABOLISM | 1.42e-03 | 33 | 24 | 2 | M2130 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.47e-03 | 134 | 24 | 3 | M3574 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 1.50e-03 | 135 | 24 | 3 | M15247 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.54e-03 | 301 | 24 | 4 | MM15983 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.57e-03 | 137 | 24 | 3 | M145 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 1.69e-03 | 36 | 24 | 2 | M39908 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 1.78e-03 | 37 | 24 | 2 | M39756 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.98e-03 | 39 | 24 | 2 | M29793 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 1.98e-03 | 39 | 24 | 2 | M653 | |
| Pathway | PID_IFNG_PATHWAY | 2.08e-03 | 40 | 24 | 2 | M161 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 2.31e-03 | 157 | 24 | 3 | MM15226 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.35e-03 | 158 | 24 | 3 | MM14791 | |
| Pathway | PID_RHOA_PATHWAY | 2.63e-03 | 45 | 24 | 2 | M12 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.87e-03 | 47 | 24 | 2 | M7946 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 2.87e-03 | 47 | 24 | 2 | M1095 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.97e-03 | 360 | 24 | 4 | M27267 | |
| Pathway | WP_RETT_SYNDROME | 2.99e-03 | 48 | 24 | 2 | M39759 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.99e-03 | 48 | 24 | 2 | M611 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 3.11e-03 | 49 | 24 | 2 | M67 | |
| Pathway | PID_NFAT_3PATHWAY | 3.63e-03 | 53 | 24 | 2 | M113 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 3.77e-03 | 54 | 24 | 2 | M3896 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 4.33e-03 | 58 | 24 | 2 | M29616 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 4.48e-03 | 59 | 24 | 2 | M261 | |
| Pubmed | 1.22e-12 | 12 | 40 | 5 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.45e-11 | 94 | 40 | 7 | 21542922 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 15063128 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.41e-08 | 5 | 40 | 3 | 12629516 | |
| Pubmed | 1.86e-08 | 25 | 40 | 4 | 36708875 | ||
| Pubmed | SMARCAD1 CHD4 PLD1 INO80 PIP4K2C ACAD11 PRDM5 UBR5 TRRAP EP300 HDAC2 | 3.48e-08 | 1116 | 40 | 11 | 31753913 | |
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 6.78e-08 | 34 | 40 | 4 | 30894540 | |
| Pubmed | 1.68e-07 | 10 | 40 | 3 | 12970426 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 8.97e-07 | 153 | 40 | 5 | 26365490 | |
| Pubmed | 1.02e-06 | 157 | 40 | 5 | 30186101 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 18664271 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21760893 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23868933 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9813240 | ||
| Pubmed | Transcriptional repression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2. | 1.29e-06 | 2 | 40 | 2 | 12782287 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 32814056 | ||
| Pubmed | Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury. | 1.29e-06 | 2 | 40 | 2 | 29437245 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9582313 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30369483 | ||
| Pubmed | Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2. | 1.29e-06 | 2 | 40 | 2 | 16873675 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34610470 | ||
| Pubmed | Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes. | 1.29e-06 | 2 | 40 | 2 | 18694819 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33495125 | ||
| Pubmed | Generation of choline for acetylcholine synthesis by phospholipase D isoforms. | 1.29e-06 | 2 | 40 | 2 | 11734063 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33368247 | ||
| Pubmed | Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight. | 1.29e-06 | 2 | 40 | 2 | 27299737 | |
| Pubmed | The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium. | 1.29e-06 | 2 | 40 | 2 | 25172550 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23383154 | ||
| Pubmed | Characterization of human PLD2 and the analysis of PLD isoform splice variants. | 1.29e-06 | 2 | 40 | 2 | 9761774 | |
| Pubmed | The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D. | 1.29e-06 | 2 | 40 | 2 | 25187519 | |
| Pubmed | Phospholipase D in TCR-Mediated Signaling and T Cell Activation. | 1.29e-06 | 2 | 40 | 2 | 29386256 | |
| Pubmed | Phospholipase D1 is a regulator of platelet-mediated inflammation. | 1.29e-06 | 2 | 40 | 2 | 28711718 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16341931 | ||
| Pubmed | Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models. | 1.29e-06 | 2 | 40 | 2 | 32661773 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24618697 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14517341 | ||
| Pubmed | Phospholipase D is essential for keratocyte-like migration of NBT-II cells. | 1.29e-06 | 2 | 40 | 2 | 18344600 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 20711340 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 37455419 | ||
| Pubmed | Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation. | 1.29e-06 | 2 | 40 | 2 | 32971863 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 25967349 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19707939 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23131846 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30207376 | ||
| Pubmed | Redundant functions of phospholipases D1 and D2 in platelet α-granule release. | 1.29e-06 | 2 | 40 | 2 | 22974101 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14999815 | ||
| Pubmed | Phospholipase D is a target for inhibition of astroglial proliferation by ethanol. | 1.29e-06 | 2 | 40 | 2 | 24262632 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30555342 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31090437 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23698760 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24103483 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9060628 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12615079 | ||
| Pubmed | Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid. | 1.29e-06 | 2 | 40 | 2 | 25523098 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36362078 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.29e-06 | 2 | 40 | 2 | 9460924 | |
| Pubmed | Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma. | 1.29e-06 | 2 | 40 | 2 | 28087476 | |
| Pubmed | Impaired brain development and reduced cognitive function in phospholipase D-deficient mice. | 1.29e-06 | 2 | 40 | 2 | 24813107 | |
| Pubmed | Expression of phospholipase D isozymes in mouse lungs during postnatal development. | 1.29e-06 | 2 | 40 | 2 | 19652486 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9395408 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 20188462 | ||
| Pubmed | Differential expression of phospholipases D1 and D2 in mouse tissues. | 1.29e-06 | 2 | 40 | 2 | 17085061 | |
| Pubmed | Organization and alternative splicing of the murine phospholipase D2 gene. | 1.29e-06 | 2 | 40 | 2 | 9560313 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 18432522 | ||
| Pubmed | Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning. | 1.29e-06 | 2 | 40 | 2 | 32209478 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 36272918 | ||
| Pubmed | Cross-talk between phospholipase D and MAP kinases activities. | 1.29e-06 | 2 | 40 | 2 | 19896495 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 17640750 | ||
| Pubmed | Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2. | 3.87e-06 | 3 | 40 | 2 | 27635759 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 17986621 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 23109426 | ||
| Pubmed | Differential Roles of Phospholipase D Proteins in FcεRI-Mediated Signaling and Mast Cell Function. | 3.87e-06 | 3 | 40 | 2 | 26392467 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21252119 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 12149127 | ||
| Pubmed | Phospholipase D confers rapamycin resistance in human breast cancer cells. | 3.87e-06 | 3 | 40 | 2 | 12813467 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15210717 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10516026 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 11032811 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 12402037 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 26122663 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9971820 | ||
| Pubmed | Regulation of Phospholipase D by Arf6 during FcγR-Mediated Phagocytosis. | 3.87e-06 | 3 | 40 | 2 | 30944160 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 5.03e-06 | 857 | 40 | 8 | 25609649 | |
| Pubmed | The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. | 7.73e-06 | 4 | 40 | 2 | 12743606 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 14744865 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 29656494 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 16622417 | ||
| Pubmed | Actin directly interacts with phospholipase D, inhibiting its activity. | 7.73e-06 | 4 | 40 | 2 | 11373276 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 23723068 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 23362269 | ||
| Pubmed | Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. | 7.73e-06 | 4 | 40 | 2 | 17220375 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 10764771 | ||
| Pubmed | Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. | 7.73e-06 | 4 | 40 | 2 | 22024166 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 7983737 | ||
| Pubmed | The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. | 7.73e-06 | 4 | 40 | 2 | 15189737 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 10926929 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 30818224 | ||
| Pubmed | Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin. | 7.73e-06 | 4 | 40 | 2 | 17853892 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 22016339 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 7.80e-06 | 910 | 40 | 8 | 36736316 | |
| Interaction | ACTL6A interactions | 2.73e-08 | 289 | 35 | 8 | int:ACTL6A | |
| Interaction | MAF interactions | 3.47e-06 | 60 | 35 | 4 | int:MAF | |
| Interaction | RUVBL1 interactions | 4.99e-06 | 575 | 35 | 8 | int:RUVBL1 | |
| Interaction | SMC1A interactions | 6.39e-06 | 418 | 35 | 7 | int:SMC1A | |
| Interaction | PRSS1 interactions | 7.62e-06 | 73 | 35 | 4 | int:PRSS1 | |
| Interaction | RUVBL2 interactions | 8.26e-06 | 616 | 35 | 8 | int:RUVBL2 | |
| Interaction | EHMT2 interactions | 1.54e-05 | 315 | 35 | 6 | int:EHMT2 | |
| Interaction | TAL1 interactions | 1.99e-05 | 93 | 35 | 4 | int:TAL1 | |
| Interaction | NAP1L4 interactions | 2.69e-05 | 206 | 35 | 5 | int:NAP1L4 | |
| Interaction | IKZF4 interactions | 3.29e-05 | 36 | 35 | 3 | int:IKZF4 | |
| Interaction | MIER2 interactions | 3.58e-05 | 37 | 35 | 3 | int:MIER2 | |
| Interaction | VHL interactions | 4.26e-05 | 561 | 35 | 7 | int:VHL | |
| Interaction | KIF13A interactions | 4.54e-05 | 40 | 35 | 3 | int:KIF13A | |
| Interaction | BRCA2 interactions | 4.68e-05 | 384 | 35 | 6 | int:BRCA2 | |
| Interaction | BUB3 interactions | 4.74e-05 | 232 | 35 | 5 | int:BUB3 | |
| Interaction | CACNG5 interactions | 4.89e-05 | 41 | 35 | 3 | int:CACNG5 | |
| Interaction | CDC20 interactions | 4.94e-05 | 234 | 35 | 5 | int:CDC20 | |
| Interaction | POU5F1 interactions | 5.49e-05 | 584 | 35 | 7 | int:POU5F1 | |
| Interaction | MED15 interactions | 7.64e-05 | 131 | 35 | 4 | int:MED15 | |
| Interaction | ZBTB7A interactions | 7.64e-05 | 131 | 35 | 4 | int:ZBTB7A | |
| Interaction | NR1I2 interactions | 7.87e-05 | 48 | 35 | 3 | int:NR1I2 | |
| Interaction | SIRT6 interactions | 8.68e-05 | 628 | 35 | 7 | int:SIRT6 | |
| Interaction | HIF1A interactions | 1.01e-04 | 441 | 35 | 6 | int:HIF1A | |
| Interaction | SUDS3 interactions | 1.02e-04 | 141 | 35 | 4 | int:SUDS3 | |
| Interaction | TNFRSF19 interactions | 1.06e-04 | 53 | 35 | 3 | int:TNFRSF19 | |
| Interaction | HSP90AA2P interactions | 1.18e-04 | 55 | 35 | 3 | int:HSP90AA2P | |
| Interaction | TCF7L2 interactions | 1.25e-04 | 285 | 35 | 5 | int:TCF7L2 | |
| Interaction | SMARCE1 interactions | 1.29e-04 | 287 | 35 | 5 | int:SMARCE1 | |
| Interaction | MRE11 interactions | 1.29e-04 | 287 | 35 | 5 | int:MRE11 | |
| Interaction | SSBP4 interactions | 1.46e-04 | 59 | 35 | 3 | int:SSBP4 | |
| Interaction | MRTFA interactions | 1.53e-04 | 60 | 35 | 3 | int:MRTFA | |
| Interaction | NANOG interactions | 1.62e-04 | 481 | 35 | 6 | int:NANOG | |
| Interaction | PRKDC interactions | 1.63e-04 | 695 | 35 | 7 | int:PRKDC | |
| Interaction | IPO7 interactions | 1.69e-04 | 304 | 35 | 5 | int:IPO7 | |
| Interaction | ANAPC7 interactions | 1.73e-04 | 162 | 35 | 4 | int:ANAPC7 | |
| Interaction | DDX41 interactions | 1.90e-04 | 166 | 35 | 4 | int:DDX41 | |
| Interaction | CSNK2A2 interactions | 1.99e-04 | 718 | 35 | 7 | int:CSNK2A2 | |
| Interaction | NFATC1 interactions | 1.99e-04 | 168 | 35 | 4 | int:NFATC1 | |
| Interaction | DHX15 interactions | 2.04e-04 | 502 | 35 | 6 | int:DHX15 | |
| Interaction | TWIST1 interactions | 2.09e-04 | 170 | 35 | 4 | int:TWIST1 | |
| Interaction | H2AC20 interactions | 2.15e-04 | 320 | 35 | 5 | int:H2AC20 | |
| Interaction | CHAF1A interactions | 2.21e-04 | 322 | 35 | 5 | int:CHAF1A | |
| Interaction | EPAS1 interactions | 2.23e-04 | 173 | 35 | 4 | int:EPAS1 | |
| Interaction | ZUP1 interactions | 2.28e-04 | 174 | 35 | 4 | int:ZUP1 | |
| Interaction | ZNF8 interactions | 2.43e-04 | 70 | 35 | 3 | int:ZNF8 | |
| Interaction | KPNA2 interactions | 2.44e-04 | 519 | 35 | 6 | int:KPNA2 | |
| Interaction | GPR156 interactions | 2.53e-04 | 71 | 35 | 3 | int:GPR156 | |
| Interaction | SLK interactions | 2.76e-04 | 183 | 35 | 4 | int:SLK | |
| Interaction | PRICKLE3 interactions | 2.86e-04 | 74 | 35 | 3 | int:PRICKLE3 | |
| Interaction | BCL11B interactions | 2.86e-04 | 74 | 35 | 3 | int:BCL11B | |
| Interaction | RPTOR interactions | 2.88e-04 | 341 | 35 | 5 | int:RPTOR | |
| Interaction | RPL4 interactions | 2.91e-04 | 764 | 35 | 7 | int:RPL4 | |
| Interaction | EHMT1 interactions | 3.06e-04 | 188 | 35 | 4 | int:EHMT1 | |
| Interaction | ZBTB17 interactions | 3.21e-04 | 77 | 35 | 3 | int:ZBTB17 | |
| Interaction | KPNA1 interactions | 3.29e-04 | 351 | 35 | 5 | int:KPNA1 | |
| Interaction | NONO interactions | 3.29e-04 | 549 | 35 | 6 | int:NONO | |
| Interaction | HELLS interactions | 3.32e-04 | 192 | 35 | 4 | int:HELLS | |
| Interaction | PPAN interactions | 3.38e-04 | 193 | 35 | 4 | int:PPAN | |
| Interaction | DVL2 interactions | 3.56e-04 | 557 | 35 | 6 | int:DVL2 | |
| Interaction | AGPS interactions | 3.59e-04 | 196 | 35 | 4 | int:AGPS | |
| Interaction | ATOH1 interactions | 3.60e-04 | 80 | 35 | 3 | int:ATOH1 | |
| Interaction | SMARCAD1 interactions | 3.66e-04 | 197 | 35 | 4 | int:SMARCAD1 | |
| Interaction | FOXJ2 interactions | 3.73e-04 | 81 | 35 | 3 | int:FOXJ2 | |
| Interaction | SMARCB1 interactions | 3.89e-04 | 364 | 35 | 5 | int:SMARCB1 | |
| Interaction | ASIC2 interactions | 3.92e-04 | 17 | 35 | 2 | int:ASIC2 | |
| Interaction | NASP interactions | 4.41e-04 | 207 | 35 | 4 | int:NASP | |
| Interaction | GPBP1L1 interactions | 4.45e-04 | 86 | 35 | 3 | int:GPBP1L1 | |
| Interaction | CDKN1A interactions | 4.45e-04 | 375 | 35 | 5 | int:CDKN1A | |
| Interaction | UPF1 interactions | 4.45e-04 | 581 | 35 | 6 | int:UPF1 | |
| Interaction | NR4A1 interactions | 4.83e-04 | 212 | 35 | 4 | int:NR4A1 | |
| Interaction | ILF2 interactions | 4.83e-04 | 590 | 35 | 6 | int:ILF2 | |
| Interaction | SMARCC1 interactions | 4.96e-04 | 384 | 35 | 5 | int:SMARCC1 | |
| Interaction | MEX3A interactions | 4.96e-04 | 384 | 35 | 5 | int:MEX3A | |
| Interaction | CDC73 interactions | 5.08e-04 | 386 | 35 | 5 | int:CDC73 | |
| Interaction | DYRK1B interactions | 5.25e-04 | 91 | 35 | 3 | int:DYRK1B | |
| Interaction | CFAP20 interactions | 5.25e-04 | 91 | 35 | 3 | int:CFAP20 | |
| Interaction | DCAF1 interactions | 5.94e-04 | 224 | 35 | 4 | int:DCAF1 | |
| Interaction | FOXG1 interactions | 5.95e-04 | 95 | 35 | 3 | int:FOXG1 | |
| Interaction | RPAP3 interactions | 6.04e-04 | 225 | 35 | 4 | int:RPAP3 | |
| Interaction | FOXK2 interactions | 6.04e-04 | 225 | 35 | 4 | int:FOXK2 | |
| Interaction | KPNA4 interactions | 6.04e-04 | 225 | 35 | 4 | int:KPNA4 | |
| Interaction | DDX46 interactions | 6.24e-04 | 227 | 35 | 4 | int:DDX46 | |
| Interaction | RPS6KA1 interactions | 6.34e-04 | 228 | 35 | 4 | int:RPS6KA1 | |
| Interaction | SMC3 interactions | 6.53e-04 | 408 | 35 | 5 | int:SMC3 | |
| Interaction | TFCP2L1 interactions | 6.71e-04 | 99 | 35 | 3 | int:TFCP2L1 | |
| Interaction | SMARCA5 interactions | 7.05e-04 | 415 | 35 | 5 | int:SMARCA5 | |
| Interaction | TMX1 interactions | 7.10e-04 | 235 | 35 | 4 | int:TMX1 | |
| Interaction | TSPAN3 interactions | 7.12e-04 | 101 | 35 | 3 | int:TSPAN3 | |
| Interaction | ZCCHC10 interactions | 7.22e-04 | 236 | 35 | 4 | int:ZCCHC10 | |
| Interaction | OGG1 interactions | 7.25e-04 | 23 | 35 | 2 | int:OGG1 | |
| Interaction | STXBP2 interactions | 7.53e-04 | 103 | 35 | 3 | int:STXBP2 | |
| Interaction | ING1 interactions | 7.53e-04 | 103 | 35 | 3 | int:ING1 | |
| Interaction | CD44 interactions | 7.57e-04 | 239 | 35 | 4 | int:CD44 | |
| Interaction | GNE interactions | 7.75e-04 | 104 | 35 | 3 | int:GNE | |
| Interaction | NR6A1 interactions | 7.90e-04 | 24 | 35 | 2 | int:NR6A1 | |
| Interaction | EID2 interactions | 7.90e-04 | 24 | 35 | 2 | int:EID2 | |
| Interaction | GFI1 interactions | 7.90e-04 | 24 | 35 | 2 | int:GFI1 | |
| Interaction | ELP2 interactions | 7.97e-04 | 105 | 35 | 3 | int:ELP2 | |
| Interaction | EIF3L interactions | 8.17e-04 | 244 | 35 | 4 | int:EIF3L | |
| Interaction | TAF6 interactions | 8.30e-04 | 245 | 35 | 4 | int:TAF6 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.62e-05 | 12 | 20 | 2 | 1305 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.57e-04 | 17 | 20 | 2 | 1197 | |
| GeneFamily | Phospholipases | 9.75e-04 | 42 | 20 | 2 | 467 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.19e-03 | 718 | 20 | 4 | 28 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.13e-06 | 155 | 33 | 4 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.88e-06 | 183 | 33 | 4 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.01e-05 | 184 | 33 | 4 | 030d5ef5e44e4d973862128fe01f7e8ef0092a06 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 186 | 33 | 4 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| Drug | 2-(hydroxymethyl)-1,4-benzodioxan | 6.49e-06 | 3 | 34 | 2 | CID000019314 | |
| Drug | sialylphospholipid | 6.49e-06 | 3 | 34 | 2 | CID000515706 | |
| Drug | Froxiprostum | 1.30e-05 | 4 | 34 | 2 | CID006434698 | |
| Drug | SCH 49210 | 3.23e-05 | 6 | 34 | 2 | CID000158548 | |
| Drug | NSC339555 | 4.50e-05 | 133 | 34 | 4 | CID000433902 | |
| Drug | Choline | 4.52e-05 | 7 | 34 | 2 | DB00122 | |
| Disease | developmental cardiac valvular defect (implicated_via_orthology) | 1.29e-06 | 2 | 34 | 2 | DOID:0080633 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 4.53e-06 | 96 | 34 | 4 | C1319315 | |
| Disease | rectum cancer (is_implicated_in) | 4.62e-05 | 9 | 34 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | Cardiac Hypertrophy | 1.16e-04 | 82 | 34 | 3 | C1383860 | |
| Disease | Cardiomegaly | 1.16e-04 | 82 | 34 | 3 | C0018800 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.53e-04 | 90 | 34 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.87e-04 | 301 | 34 | 4 | DOID:684 (is_marker_for) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 4.12e-04 | 26 | 34 | 2 | DOID:234 (is_implicated_in) | |
| Disease | ciliopathy (implicated_via_orthology) | 9.78e-04 | 40 | 34 | 2 | DOID:0060340 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHRNRAPLTHKMNKM | 16 | P61579 | |
| LPHCRTMKNVLNHMT | 366 | Q09472 | |
| RHRNRAPLTHKMNKM | 16 | O71037 | |
| RHRNRAPLTHKMNKM | 16 | Q902F8 | |
| RHRNRAPLTHKMNKM | 16 | Q9UKH3 | |
| RLHMPMLRNNRDKDL | 496 | Q6ZN30 | |
| NLHRMPMRHRKKAAD | 421 | Q5T2E6 | |
| LSRHKQHSMILVPMN | 561 | Q709F0 | |
| RHRNRAPLTHKMNKM | 16 | P61574 | |
| RHRNRAPSSHKMNKM | 16 | P61578 | |
| RHRNRAPLTHKMNKM | 16 | P61572 | |
| RHRNRAPLTHKMNKM | 16 | P61571 | |
| RHRNRAPLTHKMNKM | 16 | Q69383 | |
| RHRNRAPLTHKMNKM | 16 | P61573 | |
| LPPQNHMLLEHKMER | 496 | Q9NPH2 | |
| QLSRLHMILKPFMLR | 731 | Q9ULG1 | |
| KMLIRHKMTHNPNRP | 586 | Q9NQX1 | |
| LHRHMLIFRLPNLQM | 1336 | Q6ZRR7 | |
| MAMAQKLSHLLPSLR | 1 | Q86WK9 | |
| RMSQKVHRKMLPSNL | 96 | Q9BQS6 | |
| KLREHMQRMHNPERE | 686 | Q9NQV6 | |
| LGQLMNMLSHPVIRR | 3431 | Q7Z6Z7 | |
| HLMVVLHTLLDPRNM | 436 | Q6ZMV5 | |
| MNRAPLKRSRILHMA | 1 | Q96A29 | |
| RHRNRAPLTHKMNKM | 16 | P61570 | |
| RHRNRAPLTHKMNKM | 16 | Q69384 | |
| HQLLEKRSMGMQRPL | 681 | Q86UU0 | |
| RHRNRAPLTHKMNKM | 16 | P61565 | |
| RHRNRAPLTHKMNKM | 16 | Q902F9 | |
| MKPHRIRMTHNLLLN | 31 | Q92769 | |
| LHDMLGPHMLRRLKA | 946 | Q14839 | |
| LAMAVAHRMQPHRLK | 266 | Q1HG43 | |
| LVMRNMFSHRLPVHR | 201 | Q8TBX8 | |
| LREEIRMMSHLNHPN | 1291 | Q13233 | |
| RMMSHLNHPNIIRML | 1296 | Q13233 | |
| KDMQPHNILQRRLME | 56 | Q9NQ35 | |
| QRLSMHQRPQMHRLQ | 111 | Q96KN7 | |
| MQLRKMANHPLLHRQ | 776 | Q9H4L7 | |
| RTLMRLHPNIKVMRH | 436 | Q13393 | |
| PRKLRQMHLMIDQLM | 381 | Q9H0W8 | |
| RHRNRAPLTHKMNKM | 16 | P61575 | |
| ANLNRHSMVHMREKP | 301 | Q9UK10 | |
| LETMHKMIPLLRDHL | 1551 | Q9Y4F4 | |
| HLPRRKRMSVAHMSL | 231 | Q6PJF5 | |
| MLLHPNIKVMRHPDQ | 421 | O14939 | |
| SRIMHMQRELHPTLL | 3301 | Q9Y4A5 | |
| NPFRMKQLRQLRMVH | 871 | Q9BYX2 | |
| HRMLVVAEQPLHAMR | 2641 | O95071 | |
| KMLHVDPHQRLTAMQ | 651 | Q15349 |